Annual EBITDA
-$298.59M$198.19M+39.89%
Summary
- Current Value
- As of today, MDGL annual EBITDA is -$298.59M, up +39.89% on
- Historical Performance
- MDGL annual EBITDA is down -1.87% over the past 3 years, down -45.05% over the past 5 years
- All-Time High Comparison
- MDGL annual EBITDA is currently -459.74% below its historical high of $83.00M set on
- 3-Year Low Comparison
- MDGL annual EBITDA is +39.89% above its 3-year low of -$496.78M reached on
- Sector Comparison
- MDGL annual EBITDA is higher than 4.48% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$298.59M | +39.9% | -1.9% | -45.0% | -754.0% | |
| Quarterly EBITDA | -$92.34M | -17.0% | -18.1% | -74.7% | -777.1% | |
| TTM EBITDA | -$312.00M | +26.4% | +0.6% | -41.0% | -749.0% | |
| Price | $497.27 | +84.2% | +74.5% | +342.8% | +143.7% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $958.40M | +432.1% | +100.0% | +100.0% | +6374.4% | |
| Annual EPS | -$12.85 | +41.3% | +25.4% | +1.9% | +60.5% | |
| -$300.10M | +39.7% | -2.2% | -45.5% | -713.3% | ||
| Annual Net Income | -$288.28M | +38.1% | +2.4% | -42.5% | -669.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$293.10M | N/A | -1.9% |
| 5Y | -$205.85M | N/A | -45.0% |
| All | $83.00M | -459.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$496.78M | +39.9% | |
| 5Y | -$496.78M | +39.9% | |
| All | -$496.78M | +39.9% |
EBITDA History
FAQ
What is the current annual EBITDA of MDGL?
As of today, MDGL annual EBITDA is -$298.59M
What is 1-year change in MDGL annual EBITDA?
MDGL annual EBITDA is up +39.89% year-over-year
What is 3-year change in MDGL annual EBITDA?
MDGL annual EBITDA is down -1.87% over the past 3 years
How far is MDGL annual EBITDA from its all-time high?
MDGL annual EBITDA is currently -459.74% below its historical high of $83.00M set on December 31, 2009
How does MDGL annual EBITDA rank versus sector peers?
MDGL annual EBITDA is higher than 4.48% of companies in Healthcare sector
When is MDGL next annual earnings release?
As of today, the next annual earnings release for MDGL has not been scheduled
Quarterly EBITDA
-$92.34M$33.12M-55.93%
Summary
- Current Value
- As of today, MDGL quarterly EBITDA is -$92.34M, down -55.93% on
- Historical Performance
- MDGL quarterly EBITDA is down -16.98% year-over-year, down -18.06% over the past 3 years
- All-Time High Comparison
- MDGL quarterly EBITDA is currently -177.74% below its historical high of $118.78M set on
- 3-Year Low Comparison
- MDGL quarterly EBITDA is +43.10% above its 3-year low of -$162.27M reached on
- Sector Comparison
- MDGL quarterly EBITDA is higher than 3.78% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$92.34M | -55.9% | -17.0% | -18.1% | -74.7% | |
| Annual EBITDA | -$298.59M | – | +39.9% | -1.9% | -45.0% | |
| TTM EBITDA | -$312.00M | -4.5% | +26.4% | +0.6% | -41.0% | |
| Price | $497.27 | +15.1% | +84.2% | +74.5% | +342.8% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $311.34M | -3.0% | +126.8% | +100.0% | +100.0% | |
| Quarterly EPS | -$3.25 | -26.7% | +1.9% | +23.1% | +2.0% | |
| -$92.72M | -55.5% | -16.9% | -18.4% | -75.0% | ||
| Quarterly Net Income | -$94.39M | -61.1% | -28.9% | -22.8% | -79.6% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$46.83M | -97.2% | |
| 3Y | -$46.83M | -97.2% | |
| 5Y | -$46.83M | -97.2% | |
| All | $118.78M | -177.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$113.62M | +18.7% | |
| 3Y | -$162.27M | +43.1% | |
| 5Y | -$162.27M | +43.1% | |
| All | -$162.27M | +43.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of MDGL?
As of today, MDGL quarterly EBITDA is -$92.34M
What is MDGL quarterly EBITDA most recent change?
MDGL quarterly EBITDA was down -55.93% on March 31, 2026
What is 1-year change in MDGL quarterly EBITDA?
MDGL quarterly EBITDA is down -16.98% year-over-year
How far is MDGL quarterly EBITDA from its all-time high?
MDGL quarterly EBITDA is currently -177.74% below its historical high of $118.78M set on September 30, 2009
How does MDGL quarterly EBITDA rank versus sector peers?
MDGL quarterly EBITDA is higher than 3.78% of companies in Healthcare sector
When is MDGL next earnings release?
The next earnings release for MDGL is on
TTM EBITDA
-$312.00M$13.41M-4.49%
Summary
- Current Value
- As of today, MDGL TTM EBITDA is -$312.00M, down -4.49% on
- Historical Performance
- MDGL TTM EBITDA is up +26.39% year-over-year, up +0.59% over the past 3 years
- All-Time High Comparison
- MDGL TTM EBITDA is currently -425.79% below its historical high of $95.77M set on
- 3-Year Low Comparison
- MDGL TTM EBITDA is +42.98% above its 3-year low of -$547.18M reached on
- Sector Comparison
- MDGL TTM EBITDA is higher than 4.06% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$312.00M | -4.5% | +26.4% | +0.6% | -41.0% | |
| Annual EBITDA | -$298.59M | – | +39.9% | -1.9% | -45.0% | |
| Quarterly EBITDA | -$92.34M | -55.9% | -17.0% | -18.1% | -74.7% | |
| Price | $497.27 | +15.1% | +84.2% | +74.5% | +342.8% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $1.13B | +18.2% | +256.8% | +100.0% | +100.0% | |
| TTM EPS | -$12.80 | +0.5% | +29.1% | +29.3% | +9.0% | |
| -$313.51M | -4.5% | +26.3% | +0.3% | -41.5% | ||
| TTM Net Income | -$309.44M | -7.3% | +21.0% | +1.7% | -41.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$298.59M | -4.5% | |
| 3Y | -$298.59M | -4.5% | |
| 5Y | -$221.19M | N/A | -41.0% |
| All | $95.77M | -425.8% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$423.84M | N/A | +26.4% |
| 3Y | -$547.18M | +43.0% | |
| 5Y | -$547.18M | +43.0% | |
| All | -$547.18M | +43.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of MDGL?
As of today, MDGL TTM EBITDA is -$312.00M
What is MDGL TTM EBITDA most recent change?
MDGL TTM EBITDA was down -4.49% on March 31, 2026
What is 1-year change in MDGL TTM EBITDA?
MDGL TTM EBITDA is up +26.39% year-over-year
How far is MDGL TTM EBITDA from its all-time high?
MDGL TTM EBITDA is currently -425.79% below its historical high of $95.77M set on March 31, 2010
How does MDGL TTM EBITDA rank versus sector peers?
MDGL TTM EBITDA is higher than 4.06% of companies in Healthcare sector
When is MDGL next earnings release?
The next earnings release for MDGL is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- MDGL Official Website www.madrigalpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828026009514/0001628280-26-009514-index.htm
- MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
- MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl